{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:27:21Z","timestamp":1790602041862,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007076","name":"Airc Italian Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012621","name":"NIHR University College London Hospitals Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jhep.2024.01.032","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T06:38:10Z","timestamp":1707979090000},"page":"941-956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1485-0554","authenticated-orcid":false,"given":"Elisabetta","family":"Caon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Hodgetts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieke","family":"Blanken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0414-0727","authenticated-orcid":false,"given":"Maria Giovanna","family":"Vilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kessarin","family":"Thanapirom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Al-Akkad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeries","family":"Abu-Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0234-6828","authenticated-orcid":false,"given":"Guido","family":"Baselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7598-7319","authenticated-orcid":false,"given":"Tu Vinh","family":"Luong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5476-9785","authenticated-orcid":false,"given":"Jan-Willem","family":"Taanman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1973-224X","authenticated-orcid":false,"given":"Michele","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8909-0345","authenticated-orcid":false,"given":"Luca","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9168-4898","authenticated-orcid":false,"given":"Stefano","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1398-1541","authenticated-orcid":false,"given":"Massimo","family":"Pinzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9440-0571","authenticated-orcid":false,"given":"Krista","family":"Rombouts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2024.01.032_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cld.1061","article-title":"Global epidemiology of chronic liver disease","volume":"17","author":"Cheemerla","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.jhep.2024.01.032_bib2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.01.032_bib3","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.01.032_bib4","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/hep.30946","article-title":"The 20% rule of NASH progression: the natural history of advanced fibrosis and cirrhosis caused by NASH","volume":"70","author":"Loomba","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.01.032_bib5","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage\u00a0and\u00a0outcomes of patients with nonalcoholic fatty liver disease: a systematic Review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.01.032_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.32285","article-title":"Hepatic fibrosis 2022: unmet needs and a blueprint for the future","volume":"75","author":"Friedman","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.01.032_bib7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41575-023-00828-6","article-title":"When research on liver fibrosis made the right turn","volume":"20","author":"Pinzani","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.01.032_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jhep.2024.01.032_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2017.05.016","article-title":"Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents","volume":"121","author":"Bottcher","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jhep.2024.01.032_bib10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2014.07.018","article-title":"Cell death and cell death responses in liver disease: mechanisms and clinical relevance","volume":"147","author":"Luedde","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.01.032_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.LAB.0000069036.63405.5C","article-title":"Apoptotic body engulfment by a human stellate cell line is profibrogenic","volume":"83","author":"Canbay","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhep.2024.01.032_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.20051","article-title":"Apoptosis: the nexus of liver injury and fibrosis","volume":"39","author":"Canbay","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.01.032_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cld.2006.08.017","article-title":"Hepatic fibrosis, stellate cells, and portal hypertension","volume":"10","author":"Rockey","year":"2006","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2024.01.032_bib14","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on NAFLD genetics: from new variants to the clinic","volume":"72","author":"Trepo","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.01.032_bib15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jhep.2020.11.024","article-title":"Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores","volume":"74","author":"Bianco","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.01.032_bib16","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2024.01.032_bib17","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1074\/jbc.M109.064501","article-title":"A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis","volume":"285","author":"He","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2024.01.032_bib18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.bbalip.2013.12.006","article-title":"Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function","volume":"1841","author":"Pingitore","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2024.01.032_bib19","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1093\/hmg\/ddu121","article-title":"PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells","volume":"23","author":"Pirazzi","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jhep.2024.01.032_bib20","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/hep.23622","article-title":"Homozygosity for the patatin-like phospholipase-3\/adiponutrin I148M polymorphism influences liver fibrosis in\u00a0patients with nonalcoholic fatty liver disease","volume":"51","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.01.032_bib21","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ng.3417","article-title":"A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis","volume":"47","author":"Buch","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2024.01.032_bib22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.dld.2012.12.006","article-title":"PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease","volume":"45","author":"Valenti","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2024.01.032_bib23","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/hep.29041","article-title":"The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells","volume":"65","author":"Bruschi","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.01.032_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep4.1450","article-title":"A microphysiological system for studying nonalcoholic steatohepatitis","volume":"4","author":"Kostrzewski","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2024.01.032_bib25","first-page":"21","article-title":"PNPLA3 I148M up-regulates hedgehog and Yap signaling in human hepatic stellate cells","author":"Bruschi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2024.01.032_bib26","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/hep4.1395","article-title":"PNPLA3 I148M variant impairs liver X receptor signaling and cholesterol homeostasis in human hepatic stellate cells","volume":"3","author":"Bruschi","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2024.01.032_bib27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.01.032_bib28","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1172\/JCI65179","article-title":"Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis","volume":"122","author":"Li","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2024.01.032_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.molmet.2019.01.013","article-title":"Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice","volume":"22","author":"Linden","year":"2019","journal-title":"Mol Metab"},{"key":"10.1016\/j.jhep.2024.01.032_bib30","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1194\/jlr.M500290-JLR200","article-title":"Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members","volume":"46","author":"Lake","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2024.01.032_bib31","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1073\/pnas.1003585107","article-title":"A feed-forward loop amplifies nutritional regulation of PNPLA3","volume":"107","author":"Huang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2024.01.032_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103549","article-title":"In vitro models for non-alcoholic fatty liver disease: emerging platforms and their applications","volume":"25","author":"Ramos","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.jhep.2024.01.032_bib33","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2024.01.032_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.addr.2017.05.018","article-title":"Engineering in\u00a0vitro models of hepatofibrogenesis","volume":"121","author":"Mazza","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jhep.2024.01.032_bib35","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1038\/s41598-017-05134-1","article-title":"Rapid production of human liver scaffolds for functional tissue engineering by high shear stress oscillation-decellularization","volume":"7","author":"Mazza","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2024.01.032_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010083","article-title":"Cirrhotic human liver extracellular matrix 3D scaffolds promote smad-dependent TGF-beta1 epithelial mesenchymal transition","volume":"9","author":"Mazza","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jhep.2024.01.032_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194936","article-title":"Optimization and validation of a novel three-dimensional Co-culture system in decellularized human liver scaffold for the study of liver fibrosis and cancer","volume":"13","author":"Thanapirom","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhep.2024.01.032_bib38","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1136\/gutjnl-2019-319226","article-title":"Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker","volume":"69","author":"Baselli","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.01.032_bib39","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.01.032_bib40","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-4939-3170-5_17","article-title":"Determination and characterization of tetraspanin-associated phosphoinositide-4 kinases in primary and neoplastic liver cells","volume":"1376","author":"Rombouts","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jhep.2024.01.032_bib41","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1160\/TH08-05-0273","article-title":"Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells","volume":"100","author":"Samarakoon","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2024.01.032_bib42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12881-019-0798-7","article-title":"VARS2-linked mitochondrial encephalopathy: two case reports enlarging the clinical phenotype","volume":"20","author":"Begliuomini","year":"2019","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jhep.2024.01.032_bib43","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49178","article-title":"Distinct mitochondrial defects trigger the integrated stress response depending on the metabolic state of the cell","volume":"9","author":"Mick","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jhep.2024.01.032_bib44","first-page":"23","article-title":"VARS2 depletion leads to activation of the integrated stress response and disruptions in mitochondrial fatty acid oxidation","author":"Kayvanpour","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2024.01.032_bib45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCRESAHA.107.165472","article-title":"Role of mitochondrial dysfunction in insulin resistance","volume":"102","author":"Kim","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.jhep.2024.01.032_bib46","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.redox.2015.09.009","article-title":"Reciprocal regulation of TGF-beta and reactive oxygen species: a perverse cycle for fibrosis","volume":"6","author":"Liu","year":"2015","journal-title":"Redox Biol"},{"key":"10.1016\/j.jhep.2024.01.032_bib47","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.bbrc.2007.12.039","article-title":"Nur77 modulates hepatic lipid metabolism through suppression of SREBP1c activity","volume":"366","author":"Pols","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2024.01.032_bib48","article-title":"Knockout of Nur77 leads to amino acid, lipid, and glucose metabolism disorders in zebrafish","volume":"13","author":"Xu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jhep.2024.01.032_bib49","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1158\/1541-7786.MCR-13-0567","article-title":"The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells","volume":"12","author":"Lee","year":"2014","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jhep.2024.01.032_bib50","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nm.3777","article-title":"Orphan nuclear receptor NR4A1 regulates transforming growth factor-beta signaling and fibrosis","volume":"21","author":"Palumbo-Zerr","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2024.01.032_bib51","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fcell.2020.00158","article-title":"Reactivation of NR4A1 restrains chondrocyte inflammation and ameliorates osteoarthritis in rats","volume":"8","author":"Xiong","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jhep.2024.01.032_bib52","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nchembio.106","article-title":"Cytosporone B is an agonist for nuclear orphan receptor Nur77","volume":"4","author":"Zhan","year":"2008","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.jhep.2024.01.032_bib53","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1159\/000488838","article-title":"NR4A1 is involved in fibrogenesis in ovarian endometriosis","volume":"46","author":"Zeng","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jhep.2024.01.032_bib54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ijc.31910","article-title":"PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases","volume":"144","author":"Yang","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhep.2024.01.032_bib55","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.3390\/cimb44070218","article-title":"Mitochondrial dysfunction and chronic liver disease","volume":"44","author":"Zhang","year":"2022","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.jhep.2024.01.032_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jhep.2024.01.032_bib57","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.mito.2008.07.008","article-title":"Differential alterations in mitochondrial function induced by a choline-deficient diet: understanding fatty liver disease progression","volume":"8","author":"Teodoro","year":"2008","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jhep.2024.01.032_bib58","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2024.01.032_bib59","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1023\/A:1020195616081","article-title":"Reversible fulminant lactic acidosis and liver failure in an infant with hepatic cytochrome-c oxidase deficiency","volume":"25","author":"Lev","year":"2002","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jhep.2024.01.032_bib60","doi-asserted-by":"crossref","first-page":"G66","DOI":"10.1152\/ajpgi.00335.2013","article-title":"Metabolic profiling reveals that PNPLA3 induces widespread effects on metabolism beyond triacylglycerol remodeling in Huh-7 hepatoma cells","volume":"307","author":"Min","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2024.01.032_bib61","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.1840380426","article-title":"Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis","volume":"38","author":"Perez-Carreras","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.01.032_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/genes12091439","article-title":"The mitochondrial trigger in an animal model of nonalcoholic fatty liver disease","volume":"12","author":"Chimienti","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jhep.2024.01.032_bib63","doi-asserted-by":"crossref","first-page":"15460","DOI":"10.1074\/jbc.M309280200","article-title":"Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells","volume":"279","author":"Lee","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2024.01.032_bib64","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/labinvest.2011.55","article-title":"Fatty liver is associated with impaired activity of PPARgamma-coactivator 1alpha (PGC1alpha) and mitochondrial biogenesis in mice","volume":"91","author":"Aharoni-Simon","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhep.2024.01.032_bib65","doi-asserted-by":"crossref","DOI":"10.1177\/17562848211031394","article-title":"Mitochondrial dysfunction and liver disease: role, relevance, and potential for therapeutic modulation","volume":"14","author":"Middleton","year":"2021","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.jhep.2024.01.032_bib66","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9547613","article-title":"Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease","volume":"2018","author":"Masarone","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jhep.2024.01.032_bib67","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1042\/bj20021121","article-title":"Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state","volume":"368","author":"Kushnareva","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.jhep.2024.01.032_bib68","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-7992(90)90060-W","article-title":"The 8-hydroxyguanine content of isolated\u00a0mitochondria increases with lipid peroxidation","volume":"244","author":"Hruszkewycz","year":"1990","journal-title":"Mutat Res"},{"key":"10.1016\/j.jhep.2024.01.032_bib69","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1006\/bbrc.1993.1927","article-title":"Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells","volume":"194","author":"Parola","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2024.01.032_bib70","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0304-4165(98)00002-6","article-title":"Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE). Role of HNE adduct formation with the enzyme subunits","volume":"1380","author":"Chen","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2024.01.032_bib71","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0168-8278(03)00480-X","article-title":"4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells","volume":"40","author":"Zamara","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.01.032_bib72","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/597134","article-title":"The dual role of Nrf2 in nonalcoholic fatty liver disease: regulation of antioxidant defenses and hepatic lipid metabolism","volume":"2015","author":"Chambel","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jhep.2024.01.032_bib73","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/j.gastro.2016.09.017","article-title":"Estrogen signals through peroxisome proliferator-activated receptor-gamma coactivator 1alpha to reduce oxidative damage associated with diet-induced fatty liver disease","volume":"152","author":"Besse-Patin","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.01.032_bib74","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jhep.2020.03.051","article-title":"TGF-beta1-driven reduction of cytoglobin leads to oxidative DNA damage in stellate cells during non-alcoholic steatohepatitis","volume":"73","author":"Okina","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.01.032_bib75","first-page":"5212","article-title":"PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis","volume":"25","author":"Pingitore","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jhep.2024.01.032_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111419","article-title":"TGF-Beta in hepatic stellate cell activation and liver fibrogenesis-updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jhep.2024.01.032_bib77","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nbt1210-1248","article-title":"Towards a knowledge-based human protein Atlas","volume":"28","author":"Uhlen","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jhep.2024.01.032_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123748","article-title":"Dual pharmacological targeting of HDACs and PDE5 inhibits liver disease progression in a mouse\u00a0model of biliary inflammation and fibrosis","volume":"12","author":"Claveria-Cabello","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhep.2024.01.032_bib79","doi-asserted-by":"crossref","first-page":"36811","DOI":"10.1021\/acsomega.2c05292","article-title":"Conformationally restricted dipeptide-based nanoparticles for delivery of siRNA in experimental liver cirrhosis","volume":"7","author":"Biswas","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.jhep.2024.01.032_bib80","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/biol-2022-0047","article-title":"NR4A1 inhibits the epithelial-mesenchymal transition of hepatic stellate cells: involvement of TGF-beta-Smad2\/3\/4-ZEB signaling","volume":"17","author":"Huang","year":"2022","journal-title":"Open Life Sci"},{"key":"10.1016\/j.jhep.2024.01.032_bib81","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.yjmcc.2022.05.007","article-title":"Nuclear receptor Nur77 protects against oxidative stress by maintaining mitochondrial homeostasis via regulating mitochondrial fission and mitophagy in smooth muscle cell","volume":"170","author":"Geng","year":"2022","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jhep.2024.01.032_bib82","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1124\/molpharm.120.000148","article-title":"Metformin prevents hyperglycemia-associated, oxidative stress-induced vascular endothelial dysfunction: essential role for the orphan nuclear receptor human nuclear receptor 4A1 (Nur77)","volume":"100","author":"Venu","year":"2021","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jhep.2024.01.032_bib83","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41392-021-00542-2","article-title":"FGF1(DeltaHBS) prevents diabetic cardiomyopathy by maintaining mitochondrial homeostasis and reducing oxidative stress via AMPK\/Nur77 suppression","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jhep.2024.01.032_bib84","doi-asserted-by":"crossref","first-page":"8349","DOI":"10.1080\/21655979.2022.2053804","article-title":"Nuclear receptor 4A1 (NR4A1) silencing protects hepatocyte against hypoxia-reperfusion injury in vitro by activating liver kinase B1 (LKB1)\/AMP-activated protein kinase (AMPK) signaling","volume":"13","author":"Zheng","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.jhep.2024.01.032_bib85","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.bbrc.2017.12.070","article-title":"Berberine-induced activation of AMPK increases hepatic FGF21 expression via NUR77","volume":"495","author":"Zhou","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2024.01.032_bib86","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/liv.15587","article-title":"Long-term hypercaloric diet exacerbates metabolic liver disease in PNPLA3 I148M animals","volume":"43","author":"Su","year":"2023","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.jhep.2024.01.032_bib87","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/HEP.0000000000000574","article-title":"Impact of PNPLA3 I148M on\u00a0alpha-1 antitrypsin deficiency-dependent liver disease progression","volume":"79","author":"Volkert","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.01.032_bib88","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1038\/s41591-023-02553-8","article-title":"Interaction between estrogen receptor-alpha and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women","volume":"29","author":"Cherubini","year":"2023","journal-title":"Nat Med"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824001107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824001107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T17:26:22Z","timestamp":1715793982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827824001107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0168827824001107"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2024.01.032","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2024.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}